Zydus Americas (USA & Canada)
Zydus Americas represents a key pillar of Zydus Lifesciences’ global operations, strengthening access to high-quality, affordable therapies across the United States and Canada. With a strong presence in one of the world’s most regulated and competitive pharmaceutical markets, the business plays a critical role in delivering value through scale, quality and reliability.
The portfolio spans a wide range of generic formulations, supported by a robust pipeline of product filings and approvals. Zydus has built a consistent track record of launching differentiated products in the US market, reinforcing its position among leading generics players. The business is also advancing its presence in specialty segments, including innovative therapies and complex formulations.
Backed by integrated capabilities across research, manufacturing and supply, Zydus Americas ensures high standards of quality and compliance. Strategic investments and partnerships continue to strengthen its footprint, enabling the Company to respond to evolving healthcare needs and regulatory expectations.
Aligned with Zydus’ purpose of empowering lives through science and innovation, the Americas business continues to enhance access and affordability of therapies. By combining scientific expertise with a deep understanding of regulated markets, Zydus is delivering meaningful healthcare solutions across the US and Canada.